Evaluating new nonsense variants in the C-terminus of the protein will also be important, as previous studies have shown with BRCA2 c.9976A>T; p.Lys3326Ter that truncation of the end of protein may not significantly increase risk to BC [141,147]. The gene discussed is BRCA2; the disease is breast cancer.